PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
26-Aug-2020 GC Aesthetics announces the release of minimal-touch insertion device, HydroCone GC Aesthetics
26-Aug-2020 XBiotech-Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA Emergency Use Authorization XBiotech Inc
26-Aug-2020 MC2 Therapeutics Announces Collaboration Agreement with EPI Health on Commercialization of Newly Approved Psoriasis Drug, WYNZORA® Cream, in the US MC2 Therapeutics
26-Aug-2020 New Nasal Gel Evaluated for its Protective Action Against Human Rhinovirus 16 (HRV-A16) Infection in Nasal Epithelial Cells MetP® Pharma AG
26-Aug-2020 AstraZeneca and the World Heart Federation partner to tackle gaps in heart failure awareness and care AstraZeneca
26-Aug-2020 FINNCAP’S LIFE SCIENCES REPORT INDICATES CELL AND GENE THERAPY SECTOR IS DRIVING THE NEXT WAVE OF INNOVATION IN PHARMA FINNCAP
26-Aug-2020 UNION therapeutics A/S completes dosing of healthy volunteers with UNI911 (inhaled niclosamide) for COVID-19 UNION therapeutics A/S
26-Aug-2020 ReiThera’s COVID-19 Vaccine Candidate Enters Phase 1 Clinical Study with First Healthy Volunteer Dosed in Italy ReiThera Srl
26-Aug-2020 C3-Cloud: the digital coordinated care platform of the future University of Warwick
26-Aug-2020 ASLAN PHARMACEUTICALS RESUMES RECRUITMENT OF NEW PATIENTS INTO ASLAN004 STUDY ASLAN Pharmaceuticals
26-Aug-2020 Empagliflozin (Jardiance®) meets primary endpoint in Phase III heart failure trial with and without diabetes Boehringer Ingelheim and Eli Lilly and Company
26-Aug-2020 PTC Therapeutics Announces First Commercial Milestone Payment Following U.S. FDA Approval of Evrysdi™ (risdiplam) PTC Therapeutics, Inc
26-Aug-2020 Law firm Paul Hastings advises Acadia Pharmaceuticals in acquisition of CerSci Therapeutics Paul Hastings LLP
26-Aug-2020 Employer Branding In Pharma - Why it's Important! PharmiWeb
26-Aug-2020 172 countries & multiple candidate vaccines engaged in COVID-19 Vaccine Global Access Facility CEPI
26-Aug-2020 Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine Novavax
26-Aug-2020 How the Dutch resume elective surgery in melanoma after COVID delays SkylineDx
26-Aug-2020 Natera's Signatera(TM) Test Receives CE Mark Natera, Inc.
26-Aug-2020 Cellular Biomedicine Group to Present at Chinese Biopharmaceutical Association-USA Annual Conference Cellular Biomedicine Group
26-Aug-2020 PDL BioPharma Announces Filing of a Form 10 Registration Statement with the Securities and Exchange Commission for a Potential Spin-off of LENSAR to PDL's Stockholders PDL BioPharma, Inc.